Login / Signup

The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?

I MigliaccioL BiganzoliL Malorni
Published in: Annals of oncology : official journal of the European Society for Medical Oncology (2024)
Keyphrases
  • young adults
  • breast cancer risk
  • childhood cancer